The combination of CRISPR gene edited GATA4_HDR iPSCs with cardiac disease modelling and transcriptomics analysis provides supporting data towards disease pathogenicity for the patient GATA4 pArg283Cys VUS, that could not be determined with functional analysis in a standard laboratory cell line. This evidence concerns the gene GATA4 and heart disorder.